Digestion-Free Absolute Quantification of Conjugated Payload from ADCs Using Middle-Down Fragmentation Mass Spectrometry

Anton Rosenbaum,Jiaqi Yuan,Hui Yin Tan,Yue Huang

DOI: https://doi.org/10.26434/chemrxiv-2024-cwnf8

2024-07-01

Abstract:Antibody-drug conjugate (ADC) is a therapeutic modality that aims to improve payload delivery specificity and to reduce systemic toxicity. Considering the complex structure of ADCs, various bioanalytical methods by liquid chromatography coupled with mass spectrometry (LC-MS) and ligand binding assay (LBA) as well as hybrid LBA-LC-MS approaches have been established for ADC characterization and quantification. LCMS-based assays enable Drug-Antibody Ratio (DAR) sensitive quantification of conjugated payload. For quantitative DAR-sensitive assessment by LC-MS/MS, typically the conjugated payload is enzymatically liberated and quantified. Despite recent advances in ADC bioanalytical methods, the DAR-sensitive quantification of non-cleavable linker ADCs by LC-MS/MS remains challenging. Thus, we developed a novel middle down Collision-Induced Dissociation fragmentation approach for absolute quantification of conjugated payload for 4 different ADCs in biological matrix with minimum sample preparation. The results of these four examples demonstrate that ADCs with different linker-payload structures can be quantified, including a non-cleavable linker ADC trastuzumab emtansine. It also shows that the assay sensitivity is comparable to conventional ADC quantification method by linker-payload cleavage using enzyme, while assay dynamic range depends on factors including payload ionization and fragmentation efficiency, DAR and its distribution, and species abundance. By demonstrating absolute quantification of both cleavable and non-cleavable linker ADCs, this novel middle down intact ADC approach demonstrates its potential application in bioanalysis and analytical characterization, especially for early discovery where high-throughput screening is required as the new approach saves time and resources by not requiring enzymatic digestion for cleavable ADCs or development of anti-payload antibodies for non-cleavable linker ADCs.

Chemistry

What problem does this paper attempt to address?

This paper presents a solution to the digestion-free absolute quantification of payload conjugation in antibody-drug conjugates (ADCs). Currently, sensitive quantification of Drug-to-Antibody Ratio (DAR) using liquid chromatography-mass spectrometry (LC-MS/MS) for ADCs containing non-cleavable linkers remains challenging. The researchers developed a novel intermediate degradation collision-induced dissociation (CID) fragmentation method for absolute quantification of payload conjugation in four different ADCs in biological samples, reducing the sample preparation steps.

Traditional methods usually require enzymatic digestion to release and quantify the payload in ADCs, whereas the new method directly fragments the payload from intact ADCs through CID in the mass spectrometer, avoiding this requirement. This method is applicable to ADCs with different structures, including cleavable and non-cleavable linkers. Experimental results demonstrate that the sensitivity of this method is comparable to conventional enzymatic digestion methods, but the dynamic range may be affected by factors such as payload ionization efficiency, DAR distribution, and species abundance.

The paper showcases the effectiveness of the new method through four ADC examples, including a non-cleavable linker ADC, T-DM1. It demonstrates that different types of ADCs can be quantified reasonably and sensitively. This method improves the throughput of bioanalysis, particularly for non-cleavable linker ADCs, simplifies the analytical workflow, and may be applicable to high-throughput screening in the early discovery stage.